US appeals court allows continued sale of generic Omnicef
21 May 2009
Nancy Faigen
Please Login to read the full article.
21 May 2009
Nancy Faigen
Abbott Laboratories has failed in its bid to have a federal appeals court rule that generics of the cephalosporin antibiotic Omnicef (cefdinir) infringe its patent. The May 18th
en banc decision from the US Court of Appeals for the Federal Circuit allows a generic cefdinir product...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Watson beatsTeva on appeals overgeneric Seasonique: sued by Novartis over Exelon
- Lupin gets final US FDA approval for generic LoSeasonique
- Sandoz wants Novo's sole US Prandin patent ruled invalid in a long running case
- Momenta falls on Amphastar’s generic Lovenox approval, and sues for infringement
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
